The Role of miR-640: A Potential Suppressor in Breast Cancer via Wnt7b/β-catenin Signaling Pathway

• Chun Tang,
• Chun Tang,
• Xuehui Wang,
• Xuehui Wang,
• Changle Ji,
• Wenfang Zheng,
• Yunhe Yu,
• Xiaochong Deng,
• Xiqian Zhou,
• Lin Fang,
• Lin Fang

Affiliations

Chun Tang

Clinical Medical College of Shanghai Tenth People’s Hospital, Nanjing Medical University, Nanjing, China

Chun Tang

Department of Thyroid and Breast Surgery, Taizhou Fourth People’s Hospital, Taizhou, China

Xuehui Wang

Clinical Medical College of Shanghai Tenth People’s Hospital, Nanjing Medical University, Nanjing, China

Xuehui Wang

Department of Thyroid and Breast Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China

Changle Ji

Department of Thyroid and Breast Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China

Wenfang Zheng

Department of Thyroid and Breast Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China

Yunhe Yu

Department of Thyroid and Breast Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China

Xiaochong Deng

Department of Thyroid and Breast Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China

Xiqian Zhou

Department of Thyroid and Breast Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China

Lin Fang

Clinical Medical College of Shanghai Tenth People’s Hospital, Nanjing Medical University, Nanjing, China

Lin Fang

Department of Thyroid and Breast Surgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, China